logo
Plus   Neg
Share
Email

Verona Pharma Gets Key EU Patent Related To Ensifentrine; Stock Up

Shares of Verona Pharma plc (VRP.L,VRNA) were gaining around 2 percent in the morning trading in London after the clinical stage biopharmaceutical company focused on respiratory diseases announced Tuesday that the European Patent Office has recently granted an additional key patent relating to its lead development candidate, ensifentrine.

The patent provides intellectual property protection throughout Europe out to 2035 for a suspension formulation of ensifentrine (RPL554) suitable for nebulized administration. A corresponding patent has already issued in the US.

Ensifentrine is in Phase 2b clinical trials for chronic obstructive pulmonary disease or COPD. This first-in-class inhaled therapy has both bronchodilator and anti-inflammatory activity in a single agent and has the potential to address a major unmet need in COPD.

This patent further strengthens Verona Pharma's intellectual property estate, which provides exclusivity for ensifentrine products in key markets such as the US and Europe out to 2035.

Currently, the patent estate includes eight issued US patents and seven European patents, which have been validated in a wide range of countries throughout Europe, as well as patents in other commercially important jurisdictions such as China and Japan.

In London, Verona Pharma shares were trading at 61 pence, up 1.67 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Consumer Electronics Show have announced that it will allow sex toys to be exhibited on the floor as well as win awards next year. The organizers said CES 2020 will include tech-based sexual products on a one-year trial basis as part of the Health & Wellness product category or in the Health &... eBay Inc. (EBAY) Wednesday reported a second-quarter profit that trumped Wall Street analysts' estimates, as did revenues. Moving ahead, the company lowered its full-year revenue outlook, but lifted its earnings estimates, sending shares up nearly 5% in extended trading session. eBay's second-quarter... Shares of Netflix Inc. (NFLX) tanked 12% in extended trading session Wednesday after the online-video streaming giant reported a weak global subscriber additions, with U.S. subscribers dropping for the first-time ever. Netflix added 2.70 million subscribers globally in the quarter, far below its forecast...